Radiological markers of CSF α-synuclein aggregation in Parkinson's disease patients.

Saved in:
Bibliographic Details
Title: Radiological markers of CSF α-synuclein aggregation in Parkinson's disease patients.
Authors: Droby A; Movement Disorders Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel. amgadd@tlvmc.gov.il.; Laboratory for Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel. amgadd@tlvmc.gov.il.; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel. amgadd@tlvmc.gov.il.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel. amgadd@tlvmc.gov.il., Yoffe-Vasiliev A; Movement Disorders Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel.; Laboratory for Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel., Atias D; Movement Disorders Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel.; Laboratory for Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel., Fraser KB; Biogen Inc, Cambridge, MA, USA., Mabrouk OS; Biogen Inc, Cambridge, MA, USA., Omer N; Movement Disorders Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel.; Laboratory for Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel., Bar-Shira A; Movement Disorders Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel.; The Genomic Research Laboratory for Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Gana-Weisz M; Movement Disorders Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel.; The Genomic Research Laboratory for Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Goldstein O; Movement Disorders Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel.; The Genomic Research Laboratory for Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Artzi M; Sagol brain institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Ben Bashat D; Sagol brain institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Alcalay RN; Movement Disorders Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel.; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; The Genomic Research Laboratory for Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Orr-Urtreger A; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; The Genomic Research Laboratory for Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Shirvan JC; Biogen Inc, Cambridge, MA, USA., Cedarbaum JM; Coeruleus Clinical Sciences LLC, Woodbridge, CT, USA., Giladi N; Movement Disorders Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel.; Laboratory for Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel.; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel., Mirelman A; Movement Disorders Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel.; Laboratory for Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel.; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel., Thaler A; Movement Disorders Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel.; Laboratory for Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel.; Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Source: NPJ Parkinson's disease [NPJ Parkinsons Dis] 2025 Jan 03; Vol. 11 (1), pp. 7. Date of Electronic Publication: 2025 Jan 03.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101675390 Publication Model: Electronic Cited Medium: Print ISSN: 2373-8057 (Print) Linking ISSN: 23738057 NLM ISO Abbreviation: NPJ Parkinsons Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2373-8057
DOI:10.1038/s41531-024-00854-4